Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunochemotherapy”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Testing effectiveness (Phase 2)Looking for participantsNCT05170503
What this trial is testing

Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University 37
Not applicableNot Yet RecruitingNCT07778056
What this trial is testing

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Henan Cancer Hospital 400
Testing effectiveness (Phase 2)UnknownNCT05964101
What this trial is testing

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

Who this might be right for
NeoplasmsCarcinoma, SquamousAntineoplastic Agents
The First Affiliated Hospital of Guangzhou Medical University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07086469
What this trial is testing

Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ToripalimabSurufatinibNeoadjuvant Immunochemotherapy+2 more
Sun Yat-sen University 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04506554
What this trial is testing

Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fox Chase Cancer Center 81
Not applicableUnknownNCT05615103
What this trial is testing

The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Guangdong Provincial People's Hospital 100
Not applicableStudy completedNCT07705412
What this trial is testing

Postoperative Radiotherapy and Lymph Node Dissection After Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tongji Hospital 465
Testing effectiveness (Phase 2)UnknownNCT04459611
What this trial is testing

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE）

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableActive Not RecruitingNCT07622693
What this trial is testing

Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer

Who this might be right for
Gastric Cancer (GC)
Nanfang Hospital, Southern Medical University 80
Not applicableStudy completedNCT07236320
What this trial is testing

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Yongtao Han 200
Testing effectiveness (Phase 2)Looking for participantsNCT06354140
What this trial is testing

PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

Who this might be right for
Esophageal Squamous Cell Carcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 45
Testing effectiveness (Phase 2)Looking for participantsNCT07748325
What this trial is testing

Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdjuvant TherapyImmune Checkpoint Inhibitors
Sichuan University 100
Large-scale testing (Phase 3)Looking for participantsNCT07629817
What this trial is testing

Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 1,044
Large-scale testing (Phase 3)Looking for participantsNCT06598527
What this trial is testing

Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study

Who this might be right for
Lung Cancer (NSCLC)
Yang Hong 360
Large-scale testing (Phase 3)Looking for participantsNCT04280822
What this trial is testing

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Who this might be right for
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT05319574
What this trial is testing

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University 46
Not applicableNot Yet RecruitingNCT07697898
What this trial is testing

TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tongji Hospital 400
Not applicableLooking for participantsNCT07088354
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more
Tongji Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07452601
What this trial is testing

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 90
Next Page